Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Herpes simplex virus treatment industry 360º synopsis, 2018 – 2032 (USD Million)
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Virus type trends
2.1.4 Drug type trends
2.1.5 Site trends
2.1.6 Route of administration trends
2.1.7 Distribution channel trends
Chapter 3 Herpes Simplex Virus Treatment Market Insights
3.1 Industry landscape, 2018 – 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of herpes infection
3.2.1.2 Rising research and development
3.2.1.3 Increasing government funding and awareness
3.2.2 Industry pitfalls & challenges
3.2.2.1 Increasing product recalls
3.2.2.2 Unavailability of vaccines
3.3 Growth potential analysis
3.3.1 By virus type
3.3.2 By drug type
3.3.3 By site
3.3.4 By route of administration
3.3.5 By distribution channel
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategic dashboard, 2022
Chapter 5 Herpes Simplex Virus Treatment Market Estimates and Forecast, By Virus Type, 2018-2032 (USD Million)
5.1 Key trends, by virus type
5.2 Herpes simplex virus 1
5.3 Herpes simplex virus 2
Chapter 6 Herpes Simplex Virus Treatment Market Estimates and Forecast, By Drug Type, 2018-2032 (USD Million)
6.1 Key trends, by drug type
6.2 Acyclovir
6.3 Valacyclovir
6.4 Famciclovir
6.5 Other drug types
Chapter 7 Herpes Simplex Virus Treatment Market Estimates and Forecast, By Site, 2018-2032 (USD Million)
7.1 Key trends, by site
7.2 Oral
7.3 Genital
7.4 Other sites
Chapter 8 Herpes Simplex Virus Treatment Market Estimates and Forecast, By Route of Administration, 2018-2032 (USD Million)
8.1 Key trends, by route of administration
8.2 Oral
8.3 Injectable
8.4 Topical
Chapter 9 Herpes Simplex Virus Treatment Market Estimates and Forecast, By Distribution Channel, 2018-2032 (USD Million)
9.1 Key trends, by distribution channel
9.2 Hospital pharmacy
9.3 Retail pharmacy
9.4 Online pharmacy
Chapter 10 Herpes Simplex Virus Treatment Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)
10.1 Key trends, by region
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East & Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 Rest of Middle East & Africa
Chapter 11 Company Profiles
11.1 GlaxoSmithKline plc
11.2 Pfizer Inc
11.3 Teva Pharmaceutical Industries Ltd
11.4 Glenmark Pharmaceuticals Limited
11.5 Amneal Pharmaceuticals LLC
11.6 Novartis AG
11.7 Abbott Laboratories
11.8 Fresenius Kabi AG
11.9 Emcure Pharmaceuticals Ltd
11.10 Viatris Inc.
